| Date Filed | Type | Description |
| 06/29/2023 |
4
| SULAT JAMES R (Director) has filed a Form 4 on Mallinckrodt plc|
Txns:
| Paid exercise price by delivering 3,154 shares
@ $1.28, valued at
$4k
Disposed/sold 26,277 shares
@ $0 |
|
| 03/16/2023 |
4
| SULAT JAMES R (Director) has filed a Form 4 on Mallinckrodt plc|
Txns:
| Bought 15,000 shares
@ $8.4213, valued at
$126.3k
Bought 15,000 shares
@ $8.5437, valued at
$128.2k
|
|
| 01/05/2023 |
4
| SULAT JAMES R (Director) has filed a Form 4 on Mallinckrodt plc|
Txns:
| Granted 26,277 shares
@ $0 |
|
| 09/14/2022 |
4
| SULAT JAMES R (Director) has filed a Form 4 on Mallinckrodt plc|
Txns:
| Disposed/sold 22,533 restricted stock units
@ $0 |
|
| 07/06/2022 |
4
| SULAT JAMES R (Director) has filed a Form 4 on Mallinckrodt plc|
Txns:
| Granted 48,809 restricted stock units
@ $0 |
|
| 06/24/2022 |
3
| SULAT JAMES R (Director) has filed a Form 3 on Mallinckrodt plc |
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/01/2021 |
4
| SULAT JAMES R (Director) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $0.1028, valued at
$25.7k
|
|
| 06/04/2021 |
4
| SULAT JAMES R (Director) has filed a Form 4 on EXICURE, INC.|
Txns:
| Granted 50,000 options to buy
@ $1.71, valued at
$85.5k
|
|
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/17/2020 |
4
| SULAT JAMES R (Director) has filed a Form 4 on AMAG PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 35,090 shares
@ $0
Disposed/sold 6,000 options to buy
@ $0
Disposed/sold 317 options to buy
@ $0
Disposed/sold 3,800 options to buy
@ $0
Disposed/sold 3,575 options to buy
@ $0
Disposed/sold 12,787 options to buy
@ $0
Disposed/sold 10,110 options to buy
@ $0
Disposed/sold 7,543 options to buy
@ $0
Disposed/sold 17,326 options to buy
@ $0
Disposed/sold 21,289 options to buy
@ $0 |
|
| 06/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2020 |
4
| SULAT JAMES R (Director) has filed a Form 4 on AMAG PHARMACEUTICALS, INC.|
Txns:
| Granted 10,269 shares
@ $0
Granted 21,289 options to buy
@ $8.52, valued at
$181.4k
|
|
| 12/23/2019 |
4
| SULAT JAMES R (Director) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 300,000 options to buy
@ $0.2292, valued at
$68.8k
|
|
| 06/21/2019 |
4
| SULAT JAMES R (Director) has filed a Form 4 on MOMENTA PHARMACEUTICALS INC|
Txns:
| Granted 25,000 options to buy
@ $12.64, valued at
$316k
Exercised 4,356 restricted stock units
@ $0 |
|
| 05/29/2019 |
4
| SULAT JAMES R (Director) has filed a Form 4 on MOMENTA PHARMACEUTICALS INC|
Txns:
| Exercised 10,000 options to buy
@ $8.85, valued at
$88.5k
|
|
| 05/20/2019 |
4
| SULAT JAMES R (Director) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Granted 8,116 shares
@ $0
Granted 17,326 options to buy
@ $10.78, valued at
$186.8k
|
|
| 09/10/2018 |
4
| SULAT JAMES R (Director) has filed a Form 4 on MOMENTA PHARMACEUTICALS INC|
Txns:
| Exercised 13,500 options to buy
@ $14.79, valued at
$199.7k
|
|
| 07/20/2018 |
4
| SULAT JAMES R (Director) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 110,000 shares
@ $0
Granted 110,000 options to buy
@ $0.425, valued at
$46.8k
|
|
| 07/18/2018 |
4
| SULAT JAMES R (Director) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Exercised 30,000 options to buy
@ $0.37, valued at
$11.1k
|
|
| 06/22/2018 |
4
| SULAT JAMES R (Director) has filed a Form 4 on MOMENTA PHARMACEUTICALS INC|
Txns:
| Granted 8,855 options to buy
@ $22.3, valued at
$197.5k
Granted 4,356 restricted stock units
@ $0
Exercised 5,734 restricted stock units
@ $0 |
|
| 06/08/2018 |
4
| SULAT JAMES R (Director) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Granted 3,578 shares
@ $0
Granted 7,543 options to buy
@ $24.45, valued at
$184.4k
|
|
| 06/22/2017 |
4
| SULAT JAMES R (Director) has filed a Form 4 on MOMENTA PHARMACEUTICALS INC|
Txns:
| Granted 11,207 options to buy
@ $17.2, valued at
$192.8k
Granted 5,734 restricted stock units
@ $0 |
|
| 05/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/06/2017 |
4
| SULAT JAMES R (Director) has filed a Form 4 on Arch Therapeutics, Inc. |
| 06/27/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/31/2016 |
4
| SULAT JAMES R (Director) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Bought 111,111 shares
@ $0
Bought 83,333 options to buy
@ $0.438, valued at
$36.5k
|
|
| 05/23/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/05/2016 |
4
| SULAT JAMES R (Director) has filed a Form 4 on Arch Therapeutics, Inc. |
| 06/15/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/21/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/16/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/16/2010 |
4
| SULAT JAMES R (Director) has filed a Form 4 on MOMENTA PHARMACEUTICALS INC|
Txns:
| Granted 15,000 options to buy
@ $12.34, valued at
$185.1k
|
|
|